Product Information
CEFPROZIL 500 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.9252 per EA under NDC 57237003750. Its NADAC has been published 652 times since Apr 9, 2014.
FDA first approved this application on May 24, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237003750
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065340FDA Approved
5/24/2007
TE Code
AB
On Market Since
5/24/2007
Price Statistics
The NADAC for CEFPROZIL 500 MG TABLET has been published 652 times since Apr 9, 2014, and over the history we have for it it has declined 48.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9252 per EA |
|---|---|
| All-time high | $1.9023 (Dec 10, 2014) |
| All-time low | $0.7832 (Apr 17, 2024) |
| 52-week high | $1.0642 |
| 52-week low | $0.8921 |
| Median price | $1.1238 |
| Average price | $1.2173 |
| Largest weekly change | -37.8% (Oct 20, 2021) |
| Weeks tracked | 652 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefprozil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFPROZIL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 500 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.9252 per EA (NDC 57237003750), effective Sep 30, 2026.
How has the price of CEFPROZIL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 500 MG TABLET has declined 48.7%. It has been tracked across 652 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 500 MG TABLET?
Since Apr 9, 2014, the NADAC for CEFPROZIL 500 MG TABLET has ranged from a low of $0.7832 (Apr 17, 2024) to a high of $1.9023 (Dec 10, 2014), with a median of $1.1238 per EA.
Are there cheaper alternatives to CEFPROZIL 500 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFPROZIL 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFPROZIL 500 MG TABLET?
CEFPROZIL 500 MG TABLET (NDC 57237003750) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.